Breast Cancer
Breast Cancer
Advertisement
Rebecca AraujoDementia | July 17, 2024
Hormone therapy was associated with a 19% lower relative risk in Black women aged 65 to 74 years.
Read More
Rob DillardBreast Cancer | July 15, 2024
A study aimed to assess the long-term survival outcomes and disease patterns of male breast cancer patients.
Rob DillardBreast Cancer | July 12, 2024
Researchers developed a tool to predict nervous system side effects experienced by breast cancer patients using taxanes.
Rob DillardBreast Cancer | July 8, 2024
 A year of treatment with the antibody-drug conjugate trastuzumab emtansine effectively prevents HER2-positive BC ...
Carlos Doti, MDOncology | July 2, 2024
Carlos Doti, MD, of AstraZeneca, discusses the impact of LYNPARZA over the last decade.
Nera Lopetegui-Lia, MDAdvancements in Oncology | June 14, 2024
Dr. Lopetegui-Lia reacts to Dr. Gatti-Mays' breast cancer panel discussion from Advancements in Oncology.
Dr. Margaret Gatti-MaysAdvancements in Oncology | June 13, 2024
Dr. Margaret Gatti-Mays explains what makes The Oncology Brothers' content so important for community oncologists.
Dr. Margaret Gatti-MaysAdvancements in Oncology | June 14, 2024
Dr. Margaret Gatti-Mays explains how to address the most pressing questions in triple-negative breast cancer treatments.
Dr. Margaret Gatti-MaysAdvancements in Oncology | June 14, 2024
Dr. Gatti-Mays discusses how treatment for triple-negative breast cancer has evolved in recent years.
Dr. Margaret Gatti-MaysAdvancements in Oncology | June 12, 2024
Dr. Margaret Gatti-Mays delves into the topic of HER2 tumor expression in breast cancer.
Dr. Eric VachonBreast Cancer | June 11, 2024
A study examined the impact of relationship satisfaction and agreement between breast cancer survivors and their partners.
Dr. Margaret Gatti-MaysAdvancements in Oncology | June 12, 2024
Dr. Gatti-Mays talks about the importance of tailoring treatments to individual patients with breast cancer.
Rob DillardAdvancements in Oncology | June 7, 2024
Dr. Margaret Gatti-Mays, who specializes in breast cancer, delivers key insights on many breast cancer-related topics.
Rob DillardAdvancements in Oncology | June 6, 2024
Dr. Margaret Gatti-Mays talks with The Oncology Brothers about the right treatments for endocrine-resistant breast cancer.
Rob DillardAdvancements in Oncology | June 6, 2024
Dr. Margaret Gatti-Mays details the treatment options for BC patients in the hormone receptor-positive metastatic setting.
Rob DillardASCO 2024 | June 6, 2024
Some patients are unaware that metastatic breast cancer is incurable and that their treatment has no established end date.
Rob DillardAdvancements in Oncology | June 6, 2024
The Oncology Brothers spoke with Dr. Margaret Gatti-Mays, who provided invaluable insights on hormone receptor-positive BC.
Rob DillardASCO 2024 | June 3, 2024
Eribulin is noninferior to trastuzumab and pertuzumab plus taxane in treating HER2-positive breast cancer.
Rob DillardASCO 2024 | June 3, 2024
Episodic future thinking may help breast cancer survivors lose weight.
Rob DillardASCO 2024 | May 31, 2024
Sexual health concerns are highly prevalent in women following breast cancer diagnosis.
Advertisement
Advertisement
Advertisement
Latest News

July 18, 2024